Position in GSK
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$173,719
-$5,814 QoQ
Shares Held
3,314
+1.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#737
of 1,033 holders
Holding Since
Sep 2022
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Quent Capital, LLC holds $16,590,775 across 15 Drug Manufacturers - General names. GSK ranks #8 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
5,433 | $6,516,503 | |
| 2 | JNJ |
Johnson & Johnson
|
10,802 | $2,743,383 | |
| 3 | ABBV |
AbbVie Inc.
|
9,570 | $2,408,194 | |
| 4 | AMGN |
Amgen Inc
|
6,535 | $2,366,454 | |
| 5 | MRK |
Merck & Co., Inc.
|
9,312 | $1,196,592 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
3,680 | $464,931 | |
| 7 | PFE |
Pfizer Inc
|
15,327 | $369,074 | |
| 8 | GSK |
GSK plc
This page
|
3,314 | $173,719 |
All Filings in GSK
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $173,719 | 3,314 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $179,533 | 3,253 | Shares | Sole | 2026-04-28 | |
| 2022-09-30 | $0 | 0 | Shares | Sole | 2022-11-10 | |
| No filing history on record for this holder in this stock. | ||||||